Arteris (AIP) Financials

$31.41 +1.28 (+4.25%)

Closing price 04:00 PM Eastern

Extended Trading

$31.48 +0.07 (+0.24%)

As of 07:59 PM Eastern

Annual Income Statements for Arteris

This table shows Arteris' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-3.26	-23	-27	-37	-34	-35
Consolidated Net Income / (Loss)	-3.26	-23	-27	-37	-34	-35
Net Income / (Loss) Continuing Operations	-3.26	-23	-27	-37	-34	-35
Total Pre-Tax Income	-2.23	-22	-28	-32	-31	-33
Total Operating Income	-3.78	-22	-29	-35	-32	-33
Total Gross Profit	30	34	46	49	52	64
Total Revenue	32	38	50	54	58	71
Operating Revenue	32	38	50	54	58	71
Total Cost of Revenue	1.49	3.73	4.28	5.08	5.96	6.90
Operating Cost of Revenue	-	3.73	4.28	5.08	5.96	6.90
Total Operating Expenses	34	56	75	84	83	97
Selling, General & Admin Expense	7.33	13	16	18	18	20
Marketing Expense	9.75	12	17	21	21	27
Research & Development Expense	17	31	41	45	45	50
Total Other Income / (Expense), net	1.54	-0.47	1.34	3.35	0.46	-0.13
Interest Expense	-1.59	-	0.09	0.21	0.24	0.19
Interest & Investment Income	-	-	-	-	-2.70	-2.81
Other Income / (Expense), net	-0.05	-0.47	1.43	3.56	3.40	2.87
Income Tax Expense	1.03	1.04	-0.42	1.68	2.50	1.48
Basic Earnings per Share	($0.19)	($1.06)	($0.84)	($1.03)	($0.86)	($0.82)
Weighted Average Basic Shares Outstanding	17.58M	21.97M	32.58M	35.68M	38.91M	42.29M
Diluted Earnings per Share	($0.19)	($1.06)	($0.84)	($1.03)	($0.86)	($0.82)
Weighted Average Diluted Shares Outstanding	17.58M	21.97M	32.58M	35.68M	38.91M	42.29M
Weighted Average Basic & Diluted Shares Outstanding	-	31.61M	34.79M	37.85M	40.95M	45.47M

This table shows Arteris' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-9.17	-8.15	-11	-9.40	-8.34	-7.69	-8.20	-8.12	-9.13	-8.99	-8.50
Consolidated Net Income / (Loss)	-9.17	-8.15	-11	-9.40	-8.34	-7.69	-8.20	-8.12	-9.13	-8.99	-8.50
Net Income / (Loss) Continuing Operations	-9.17	-8.15	-11	-9.40	-8.34	-7.69	-8.20	-8.12	-9.13	-8.99	-8.50
Total Pre-Tax Income	-7.88	-7.63	-8.41	-8.27	-6.64	-7.20	-6.32	-7.04	-7.50	-8.13	-11
Total Operating Income	-8.68	-8.45	-9.25	-9.13	-7.44	-7.92	-7.10	-7.71	-8.25	-8.71	-8.47
Total Gross Profit	14	12	11	11	13	13	14	15	15	16	18
Total Revenue	15	13	13	13	15	15	15	17	17	17	20
Operating Revenue	15	13	13	13	15	15	15	17	17	17	20
Total Cost of Revenue	1.23	1.28	1.45	1.47	1.46	1.46	1.58	1.53	1.74	1.77	1.86
Operating Cost of Revenue	1.23	1.28	1.45	1.47	1.46	1.46	1.58	1.53	1.74	1.77	1.86
Total Operating Expenses	22	20	20	21	21	21	21	23	23	24	27
Selling, General & Admin Expense	4.50	4.43	4.61	4.32	4.83	4.29	4.12	4.32	4.50	4.86	6.45
Marketing Expense	5.60	5.02	5.03	5.46	5.01	4.96	5.37	6.53	6.34	6.85	7.07
Research & Development Expense	12	11	11	11	11	12	12	12	12	13	13
Total Other Income / (Expense), net	0.81	0.82	0.84	0.86	0.80	0.72	0.78	0.67	0.74	0.59	-2.14
Interest Expense	0.03	0.08	0.08	0.08	0.07	0.06	0.05	0.05	0.04	0.05	0.05
Other Income / (Expense), net	0.84	0.90	0.92	0.94	0.87	0.78	0.82	0.72	0.79	0.64	0.73
Income Tax Expense	0.56	-0.40	1.22	0.37	0.98	-0.09	1.25	0.27	0.85	0.38	-0.02
Basic Earnings per Share	($0.26)	($0.23)	($0.28)	($0.25)	($0.22)	($0.20)	($0.19)	($0.20)	($0.22)	($0.21)	($0.19)
Weighted Average Basic Shares Outstanding	35.25M	36.01M	35.68M	37.71M	38.48M	39.30M	38.91M	40.85M	41.82M	42.74M	42.29M
Diluted Earnings per Share	($0.26)	($0.23)	($0.28)	($0.25)	($0.22)	($0.20)	($0.19)	($0.20)	($0.22)	($0.21)	($0.19)
Weighted Average Diluted Shares Outstanding	35.25M	36.01M	35.68M	37.71M	38.48M	39.30M	38.91M	40.85M	41.82M	42.74M	42.29M
Weighted Average Basic & Diluted Shares Outstanding	36.07M	36.85M	37.85M	38.48M	39.26M	40.18M	40.95M	41.98M	42.65M	43.68M	45.47M

This table details how cash moves in and out of Arteris' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-2.19	74	-48	-23	-0.01	20
Net Cash From Operating Activities	2.16	-0.81	-6.77	-16	-0.72	6.73
Net Cash From Continuing Operating Activities	2.16	-0.81	-6.77	-16	-0.72	6.73
Net Income / (Loss) Continuing Operations	-3.26	-23	-27	-37	-34	-35
Consolidated Net Income / (Loss)	-3.26	-23	-27	-37	-34	-35
Depreciation Expense	0.94	1.49	2.10	3.07	3.36	3.38
Amortization Expense	-	0.00	-0.57	-2.07	-1.88	-1.55
Non-Cash Adjustments To Reconcile Net Income	-0.57	5.57	12	18	19	22
Changes in Operating Assets and Liabilities, net	5.06	16	7.13	1.95	13	18
Net Cash From Investing Activities	-5.15	-1.36	-37	-4.69	0.97	12
Net Cash From Continuing Investing Activities	-5.15	-1.36	-37	-4.69	0.97	12
Purchase of Property, Plant & Equipment	-0.65	-0.81	-1.05	-1.50	-0.32	-1.39
Purchase of Investments	-	0.00	-35	-48	-37	-30
Sale and/or Maturity of Investments	-	0.00	0.24	45	38	43
Net Cash From Financing Activities	0.79	76	-4.15	-2.92	-0.26	1.42
Net Cash From Continuing Financing Activities	0.79	76	-4.15	-2.92	-0.26	1.42
Repayment of Debt	-0.61	-1.12	0.00	0.08	0.06	0.07
Issuance of Common Equity	0.00	80	-	0.00	0.54	0.98
Other Financing Activities, net	1.40	0.60	-3.90	-3.00	-0.86	0.36
Cash Income Taxes Paid	1.53	0.49	0.79	1.29	1.55	2.82

This table details how cash moves in and out of Arteris' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	-1.78	-7.71	-4.93	12	-3.99	-4.30	-4.15	2.69	-0.27	1.38	16
Net Cash From Operating Activities	-1.56	-2.81	-2.98	0.48	0.31	1.12	-2.63	2.86	-2.49	3.19	3.17
Net Cash From Continuing Operating Activities	-1.56	-2.81	-2.98	0.48	0.31	1.12	-2.63	2.86	-2.49	3.19	3.17
Net Income / (Loss) Continuing Operations	-9.17	-8.15	-11	-9.40	-8.34	-7.69	-8.20	-8.12	-9.13	-8.99	-8.50
Consolidated Net Income / (Loss)	-9.17	-8.15	-11	-9.40	-8.34	-7.69	-8.20	-8.12	-9.13	-8.99	-8.50
Depreciation Expense	0.67	0.97	0.83	0.83	0.80	0.84	0.89	0.84	0.85	0.84	0.84
Amortization Expense	-0.53	-0.50	-0.49	-0.48	-0.46	-0.48	-0.47	-0.42	-0.39	-0.38	-0.36
Non-Cash Adjustments To Reconcile Net Income	5.00	4.62	4.73	4.45	4.48	5.07	4.80	5.31	5.47	5.45	5.56
Changes in Operating Assets and Liabilities, net	2.47	0.26	2.50	5.08	3.84	3.37	0.36	5.25	0.72	6.27	5.63
Net Cash From Investing Activities	-0.05	-3.69	-1.37	12	-4.36	-4.65	-1.93	-0.12	0.71	-1.63	13
Net Cash From Continuing Investing Activities	-0.05	-3.69	-1.37	12	-4.36	-4.65	-1.93	-0.12	0.71	-1.63	13
Purchase of Property, Plant & Equipment	-0.62	-0.34	-0.43	-0.20	-0.05	-0.03	-0.05	-0.18	-0.36	-0.72	-0.13
Purchase of Investments	-15	-16	-12	-3.42	-9.56	-13	-11	-8.74	-8.42	-8.15	-4.22
Sale and/or Maturity of Investments	15	13	12	16	5.25	8.40	9.30	8.80	9.48	7.23	17
Net Cash From Financing Activities	-0.18	-1.21	-0.58	0.04	0.06	-0.78	0.41	-0.05	1.51	-0.18	0.14
Net Cash From Continuing Financing Activities	-0.18	-1.21	-0.58	0.04	0.06	-0.78	0.41	-0.05	1.51	-0.18	0.14
Repayment of Debt	-	-	-	0.00	-	0.06	-	0.03	-	0.07	-0.03
Issuance of Common Equity	-	-	-	-	-	-	-	-	-	-	0.45
Other Financing Activities, net	-0.18	-1.29	-0.58	0.04	0.06	-0.83	-0.12	-0.08	0.97	-0.25	-0.28

This table presents Arteris' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	43	120	116	103	106	115
Total Current Assets	29	107	81	58	69	82
Cash & Equivalents	12	86	37	14	14	34
Short-Term Investments	-	0.00	31	27	30	21
Accounts Receivable	14	14	7.14	12	21	19
Prepaid Expenses	2.86	6.95	5.82	5.25	4.63	8.61
Plant, Property, & Equipment, net	2.37	2.44	3.62	5.75	4.02	3.87
Total Noncurrent Assets	11	11	31	39	33	29
Long-Term Investments	-	0.00	16	20	14	7.94
Goodwill	2.68	2.68	4.22	4.18	4.18	4.18
Intangible Assets	3.41	2.96	4.58	3.86	3.02	2.17
Other Noncurrent Operating Assets	5.33	5.72	5.67	10	12	14
Total Liabilities & Shareholders' Equity	43	120	116	103	106	115
Total Liabilities	49	68	78	88	107	130
Total Current Liabilities	28	42	44	46	59	73
Accounts Payable	1.12	1.72	0.57	0.18	0.54	0.34
Accrued Expenses	7.25	11	12	12	16	19
Current Deferred Revenue	18	28	29	32	40	51
Other Current Liabilities	1.41	1.79	2.16	2.85	2.40	2.40
Total Noncurrent Liabilities	21	25	34	41	48	56
Noncurrent Deferred Revenue	15	21	32	34	43	50
Other Noncurrent Operating Liabilities	5.79	4.27	2.48	7.31	5.23	6.04
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-12	53	38	15	-1.19	-15
Total Preferred & Common Equity	-12	53	38	15	-1.19	-15
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-12	53	38	15	-1.19	-15
Common Stock	3.63	92	104	118	136	157
Retained Earnings	-16	-39	-66	-103	-137	-172
Accumulated Other Comprehensive Income / (Loss)	-0.03	-0.08	0.10	0.12	0.14	0.18

This table presents Arteris' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Total Assets	107	102	101	96	98	98	107	108
Total Current Assets	70	62	62	59	63	57	62	61
Cash & Equivalents	26	19	26	22	18	16	16	17
Short-Term Investments	29	28	19	24	31	26	22	22
Accounts Receivable	9.58	10	12	8.95	8.72	10	19	16
Prepaid Expenses	5.86	5.25	4.72	4.20	5.40	4.82	4.83	5.57
Plant, Property, & Equipment, net	5.17	5.43	5.24	4.67	4.06	3.43	4.29	4.46
Total Noncurrent Assets	31	35	34	33	31	37	41	42
Long-Term Investments	16	20	16	15	12	18	20	21
Goodwill	4.18	4.18	4.18	4.18	4.18	4.18	4.18	4.18
Intangible Assets	4.19	4.05	3.66	3.47	3.25	2.80	2.58	2.36
Other Noncurrent Operating Assets	6.71	6.84	10	10	11	13	14	15
Total Liabilities & Shareholders' Equity	107	102	101	96	98	98	107	108
Total Liabilities	80	80	92	91	96	103	114	119
Total Current Liabilities	44	45	50	52	54	57	63	67
Accounts Payable	0.21	0.45	0.75	0.34	0.14	0.23	0.86	0.52
Accrued Expenses	11	12	13	12	13	14	15	17
Current Deferred Revenue	30	30	34	37	39	40	43	46
Other Current Liabilities	2.29	2.19	2.85	2.74	2.12	2.43	3.06	2.80
Total Noncurrent Liabilities	36	36	42	39	41	47	52	52
Noncurrent Deferred Revenue	32	23	35	33	27	41	46	46
Other Noncurrent Operating Liabilities	3.80	13	6.91	6.64	15	5.71	6.18	6.04
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	27	22	9.55	5.28	2.21	-4.82	-7.53	-11
Total Preferred & Common Equity	27	22	9.55	5.28	2.21	-4.82	-7.53	-11
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	27	22	9.55	5.28	2.21	-4.82	-7.53	-11
Common Stock	111	115	122	126	131	140	146	151
Retained Earnings	-85	-93	-113	-121	-129	-145	-154	-163
Accumulated Other Comprehensive Income / (Loss)	0.03	0.05	0.05	0.04	0.17	0.13	0.22	0.26

This table displays calculated financial ratios and metrics derived from Arteris' official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	19.02%	33.05%	6.53%	7.56%	22.27%
EBITDA Growth	0.00%	-617.39%	-24.84%	-18.10%	12.67%	-6.46%
EBIT Growth	0.00%	-481.11%	-23.35%	-15.14%	10.73%	-7.34%
NOPAT Growth	0.00%	-476.25%	-32.58%	-21.78%	10.09%	-4.88%
Net Income Growth	0.00%	-617.30%	-17.12%	-34.62%	8.76%	-3.29%
EPS Growth	0.00%	-457.89%	20.75%	-22.62%	16.50%	4.65%
Operating Cash Flow Growth	0.00%	-137.63%	-731.33%	-132.44%	95.42%	1,035.14%
Free Cash Flow Firm Growth	0.00%	0.00%	-3,151.95%	-307.23%	63.63%	41.39%
Invested Capital Growth	0.00%	-88.30%	-42.58%	1.21%	-27.95%	-30.05%
Revenue Q/Q Growth	0.00%	0.00%	-0.46%	2.48%	5.45%	7.05%
EBITDA Q/Q Growth	0.00%	0.00%	-4.49%	-0.04%	7.40%	-5.14%
EBIT Q/Q Growth	0.00%	0.00%	-2.94%	-0.93%	6.79%	-5.06%
NOPAT Q/Q Growth	0.00%	0.00%	-6.57%	-0.54%	6.36%	-4.30%
Net Income Q/Q Growth	0.00%	0.00%	2.06%	-9.92%	6.50%	-0.87%
EPS Q/Q Growth	0.00%	0.00%	5.62%	-7.29%	9.47%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	39.30%	-112.53%	-19.69%	32.58%	622.42%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	6.25%	-2.69%	44.01%
Invested Capital Q/Q Growth	0.00%	0.00%	-1.15%	-5.32%	-1.02%	-8.09%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	95.31%	90.15%	91.50%	90.54%	89.67%	90.23%
EBITDA Margin	-9.09%	-54.79%	-51.41%	-57.00%	-46.27%	-40.29%
Operating Margin	-11.87%	-57.48%	-57.28%	-65.48%	-54.74%	-46.95%
EBIT Margin	-12.03%	-58.73%	-54.45%	-58.85%	-48.85%	-42.88%
Profit (Net Income) Margin	-10.25%	-61.76%	-54.36%	-68.70%	-58.27%	-49.23%
Tax Burden Percent	145.93%	105.15%	99.52%	115.96%	118.28%	104.43%
Interest Burden Percent	58.37%	100.00%	100.32%	100.67%	100.87%	109.93%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	51.78%	-100.34%	-60.56%	-140.09%	-483.48%	439.27%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-8.96%	-27.26%	-23.25%	-28.93%	-26.99%	-27.37%
Return on Assets (ROA)	-7.63%	-28.66%	-23.21%	-33.78%	-32.20%	-31.42%
Return on Common Equity (ROCE)	98.75%	-88.05%	-60.56%	-140.09%	-483.48%	439.27%
Return on Equity Simple (ROE_SIMPLE)	27.15%	-44.20%	-72.96%	-244.12%	2,831.48%	0.00%
Net Operating Profit after Tax (NOPAT)	-2.64	-15	-20	-25	-22	-23
NOPAT Margin	-8.31%	-40.24%	-40.10%	-45.84%	-38.32%	-32.87%
Net Nonoperating Expense Percent (NNEP)	-5.51%	-16.80%	-8.44%	-16.81%	-19.26%	-19.14%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-162.88%	1,861.72%	158.53%
Cost of Revenue to Revenue	4.69%	9.85%	8.50%	9.46%	10.33%	9.77%
SG&A Expenses to Revenue	23.04%	35.28%	32.49%	33.44%	30.41%	28.52%
R&D to Revenue	53.50%	81.38%	81.72%	84.09%	77.97%	70.71%
Operating Expenses to Revenue	107.19%	147.63%	148.78%	156.02%	144.41%	137.18%
Earnings before Interest and Taxes (EBIT)	-3.83	-22	-27	-32	-28	-30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-2.89	-21	-26	-31	-27	-28
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	12.47	3.83	14.37	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	13.96	5.00	30.72	0.00	0.00
Price to Revenue (P/Rev)	2.20	17.43	2.85	4.04	7.09	9.59
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	2.03	15.16	1.18	2.90	6.09	8.71
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	29.83	0.00	0.00	0.00	0.00	91.28
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	2,834.40	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	-0.09	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	1.78	-2.08	-1.88	-2.77	-8.60	7.63
Leverage Ratio	-6.79	3.50	2.61	4.15	15.02	-13.98
Compound Leverage Factor	-3.96	3.50	2.62	4.18	15.15	-15.37
Debt to Total Capital	-9.71%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	-9.71%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-99.53%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	209.24%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	-0.19	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	3.87	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.21	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	4.23	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.81	5.75	0.34	-0.27	0.26	0.89
Noncontrolling Interest Sharing Ratio	-90.72%	12.26%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	1.03	2.51	1.86	1.26	1.17	1.13
Quick Ratio	0.92	2.35	1.72	1.15	1.09	1.01
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.20	-6.18	-25	-9.15	-5.36
Operating Cash Flow to CapEx	330.73%	-100.74%	-643.86%	-1,046.51%	-222.22%	485.09%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-69.44	-119.28	-37.52	-27.80
Operating Cash Flow to Interest Expense	0.00	0.00	-76.03	-74.55	-2.95	34.89
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-87.84	-81.67	-4.28	27.69
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.74	0.46	0.43	0.49	0.55	0.64
Accounts Receivable Turnover	2.22	2.68	4.79	5.61	3.54	3.55
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	13.45	15.77	16.64	11.46	11.82	17.89
Accounts Payable Turnover	1.34	2.63	3.73	13.45	16.52	15.69
Days Sales Outstanding (DSO)	164.65	136.03	76.13	65.11	103.10	102.89
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	273.20	138.82	97.79	27.14	22.10	23.27
Cash Conversion Cycle (CCC)	-108.55	-2.79	-21.66	37.97	81.00	79.62
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	-17	-33	-47	-46	-59	-77
Invested Capital Turnover	-1.82	-1.50	-1.26	-1.15	-1.09	-1.03
Increase / (Decrease) in Invested Capital	0.00	-15	-14	0.57	-13	-18
Enterprise Value (EV)	65	574	59	156	351	615
Market Capitalization	70	660	144	217	409	677
Book Value per Share	($0.68)	$1.69	$1.12	$0.41	($0.03)	($0.34)
Tangible Book Value per Share	($1.03)	$1.51	$0.86	$0.19	($0.21)	($0.48)
Total Capital	-5.74	53	38	15	-1.19	-15
Total Debt	0.56	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-11	-86	-84	-61	-58	-63
Capital Expenditures (CapEx)	0.65	0.81	1.05	1.50	0.32	1.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-10	-22	-31	-29	-34	-45
Debt-free Net Working Capital (DFNWC)	1.28	64	37	12	9.80	9.19
Net Working Capital (NWC)	0.73	64	37	12	9.80	9.19
Net Nonoperating Expense (NNE)	0.62	8.15	7.19	12	12	12
Net Nonoperating Obligations (NNO)	-11	-86	-84	-61	-58	-63
Total Depreciation and Amortization (D&A)	0.94	1.49	1.53	1.00	1.49	1.83
Debt-free, Cash-free Net Working Capital to Revenue	-32.88%	-57.23%	-60.96%	-54.31%	-58.97%	-64.34%
Debt-free Net Working Capital to Revenue	4.03%	169.44%	74.32%	22.41%	16.98%	13.02%
Net Working Capital to Revenue	2.28%	169.44%	74.32%	22.41%	16.98%	13.02%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($1.06)	($0.84)	($1.03)	($0.86)	($0.82)
Adjusted Weighted Average Basic Shares Outstanding	0.00	21.97M	32.58M	35.68M	38.91M	42.29M
Adjusted Diluted Earnings per Share	$0.00	($1.06)	($0.84)	($1.03)	($0.86)	($0.82)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	21.97M	32.58M	35.68M	38.91M	42.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	31.61M	34.79M	37.85M	40.95M	45.47M
Normalized Net Operating Profit after Tax (NOPAT)	-2.64	-15	-20	-25	-22	-23
Normalized NOPAT Margin	-8.31%	-40.24%	-40.10%	-45.84%	-38.32%	-32.87%
Pre Tax Income Margin	-7.02%	-58.73%	-54.63%	-59.25%	-49.27%	-47.14%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	-308.21	-149.69	-115.56	-156.81
NOPAT to Interest Expense	0.00	0.00	-226.96	-116.58	-90.64	-120.19
EBIT Less CapEx to Interest Expense	0.00	0.00	-320.02	-156.81	-116.89	-164.01
NOPAT Less CapEx to Interest Expense	0.00	0.00	-238.77	-123.71	-91.97	-127.38
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-15.06%	-0.93%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Arteris' official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.59%	5.37%	11.61%	-1.57%	-1.08%	10.84%	23.87%	27.69%	13.22%	18.32%	30.01%
EBITDA Growth	-61.52%	-3.19%	-0.14%	-0.54%	19.08%	4.42%	26.70%	16.26%	-12.32%	-12.43%	-23.72%
EBIT Growth	-48.10%	-1.90%	-3.62%	-4.45%	16.21%	5.44%	24.65%	14.74%	-13.47%	-13.07%	-23.21%
NOPAT Growth	-60.03%	-9.01%	-2.09%	-4.31%	14.30%	6.32%	23.21%	15.61%	-10.85%	-10.04%	-19.22%
Net Income Growth	-61.70%	-6.10%	-46.10%	-4.36%	8.96%	5.72%	22.17%	13.63%	-9.42%	-16.96%	-3.66%
EPS Growth	-44.44%	0.00%	-33.33%	3.85%	15.38%	13.04%	32.14%	20.00%	0.00%	-5.00%	0.00%
Operating Cash Flow Growth	-885.35%	46.17%	-661.89%	105.69%	120.00%	140.02%	11.68%	499.58%	-899.04%	183.88%	220.49%
Free Cash Flow Firm Growth	-121.88%	-132.93%	-191.73%	28.13%	164.39%	210.46%	213.48%	211.60%	-32.14%	-28.43%	48.96%
Invested Capital Growth	7.41%	5.12%	1.21%	-20.91%	-25.78%	-33.40%	-27.95%	-25.75%	-17.94%	-21.55%	-30.05%
Revenue Q/Q Growth	12.01%	-9.91%	-5.80%	3.54%	12.57%	0.95%	5.27%	6.73%	-0.18%	5.49%	15.68%
EBITDA Q/Q Growth	1.18%	8.02%	-12.80%	1.94%	20.46%	-8.64%	13.51%	-12.03%	-6.69%	-8.75%	4.82%
EBIT Q/Q Growth	0.01%	3.73%	-10.28%	1.61%	19.79%	-8.64%	12.12%	-11.34%	-6.75%	-8.26%	4.25%
NOPAT Q/Q Growth	0.85%	2.65%	-9.42%	1.24%	18.54%	-6.42%	10.32%	-8.53%	-7.01%	-5.65%	2.83%
Net Income Q/Q Growth	-1.72%	11.04%	-29.29%	10.80%	11.26%	7.87%	-6.73%	1.01%	-12.42%	1.52%	5.42%
EPS Q/Q Growth	0.00%	11.54%	-21.74%	10.71%	12.00%	9.09%	5.00%	-5.26%	-10.00%	4.55%	9.52%
Operating Cash Flow Q/Q Growth	81.46%	-80.45%	-6.17%	116.01%	-34.80%	261.09%	-334.28%	208.70%	-186.89%	228.29%	-0.56%
Free Cash Flow Firm Q/Q Growth	-586.42%	13.75%	15.10%	135.97%	144.45%	47.97%	-12.78%	-1.23%	-46.76%	56.06%	81.51%
Invested Capital Q/Q Growth	-3.60%	0.43%	-5.32%	-11.30%	-7.77%	-5.60%	-1.02%	-9.38%	-1.08%	-8.83%	-8.09%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	91.69%	90.36%	88.42%	88.66%	90.00%	90.07%	89.83%	90.77%	89.44%	89.86%	90.76%
EBITDA Margin	-52.30%	-53.40%	-63.94%	-60.55%	-42.79%	-46.05%	-37.83%	-39.71%	-42.44%	-43.76%	-36.00%
Operating Margin	-58.93%	-63.68%	-73.97%	-70.55%	-51.05%	-53.82%	-45.85%	-46.62%	-49.98%	-50.06%	-42.05%
EBIT Margin	-53.26%	-56.92%	-66.63%	-63.32%	-45.12%	-48.56%	-40.53%	-42.28%	-45.22%	-46.40%	-38.41%
Profit (Net Income) Margin	-62.20%	-61.42%	-84.30%	-72.63%	-57.25%	-52.25%	-52.97%	-49.12%	-55.33%	-51.65%	-42.23%
Tax Burden Percent	116.38%	106.83%	125.38%	113.65%	125.59%	106.78%	129.75%	115.39%	121.67%	110.63%	80.21%
Interest Burden Percent	100.34%	101.02%	100.90%	100.93%	101.03%	100.77%	100.72%	100.69%	100.56%	100.61%	137.07%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-91.08%	-107.53%	-140.09%	-180.38%	-226.38%	-296.85%	-483.48%	-1,369.57%	2,940.73%	745.58%	439.27%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-24.15%	-26.97%	-32.76%	-32.45%	-23.67%	-26.59%	-22.40%	-25.96%	-28.14%	-29.78%	-24.52%
Return on Assets (ROA)	-28.21%	-29.11%	-41.45%	-37.22%	-30.03%	-28.62%	-29.27%	-30.17%	-34.43%	-33.15%	-26.95%
Return on Common Equity (ROCE)	-91.08%	-107.53%	-140.09%	-180.38%	-226.38%	-296.85%	-483.48%	-1,369.57%	2,940.73%	745.58%	439.27%
Return on Equity Simple (ROE_SIMPLE)	-122.86%	-152.27%	0.00%	-390.34%	0.00%	0.00%	0.00%	671.15%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-6.08	-5.92	-6.47	-6.39	-5.21	-5.54	-4.97	-5.40	-5.77	-6.10	-5.93
NOPAT Margin	-41.25%	-44.58%	-51.78%	-49.38%	-35.74%	-37.68%	-32.10%	-32.64%	-34.99%	-35.04%	-29.43%
Net Nonoperating Expense Percent (NNEP)	-3.75%	-2.93%	-5.57%	-4.44%	-4.75%	-3.38%	-5.40%	-4.50%	-5.64%	-4.78%	-4.27%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-42.87%	-66.98%	-98.74%	-250.94%	418.47%	111.92%	76.68%	53.28%	40.51%
Cost of Revenue to Revenue	8.31%	9.64%	11.58%	11.34%	10.00%	9.93%	10.17%	9.23%	10.56%	10.14%	9.24%
SG&A Expenses to Revenue	30.57%	33.34%	36.89%	33.38%	33.13%	29.13%	26.59%	26.15%	27.28%	27.91%	32.02%
R&D to Revenue	82.03%	82.85%	85.28%	83.69%	73.53%	81.04%	74.45%	71.75%	73.75%	72.66%	65.69%
Operating Expenses to Revenue	150.62%	154.04%	162.39%	159.21%	141.05%	143.89%	135.68%	137.39%	139.43%	139.91%	132.81%
Earnings before Interest and Taxes (EBIT)	-7.85	-7.56	-8.33	-8.20	-6.58	-7.14	-6.28	-6.99	-7.46	-8.08	-7.74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-7.71	-7.09	-8.00	-7.84	-6.24	-6.78	-5.86	-6.57	-7.00	-7.62	-7.25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.96	10.66	14.37	28.26	54.78	137.20	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	13.00	17.02	30.72	158.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.67	4.48	4.04	5.05	5.42	5.54	7.09	4.62	6.33	6.53	9.59
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	3.29	3.22	2.90	3.90	4.28	4.42	6.09	3.64	5.41	5.62	8.71
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	134.02	0.00	397.88	91.28
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-2.27	-2.45	-2.77	-3.28	-4.10	-5.24	-8.60	-25.66	52.78	13.08	7.63
Leverage Ratio	3.14	3.54	4.15	5.05	6.31	8.25	15.02	42.26	-90.17	-22.24	-13.98
Compound Leverage Factor	3.15	3.58	4.18	5.10	6.38	8.31	15.12	42.55	-90.68	-22.37	-19.16
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	1.24	0.96	0.47	0.61	0.56	0.48	0.94	-0.02	0.43	0.35	1.53
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.61	1.39	1.26	1.24	1.14	1.16	1.17	1.02	0.98	0.91	1.13
Quick Ratio	1.48	1.27	1.15	1.15	1.06	1.06	1.09	0.93	0.91	0.83	1.01
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-9.62	-8.30	-7.04	2.53	6.19	9.16	7.99	7.89	4.20	6.56	12
Operating Cash Flow to CapEx	-252.85%	-825.29%	-696.03%	243.37%	661.70%	3,622.58%	-5,262.00%	1,562.84%	-700.00%	445.25%	2,365.67%
Free Cash Flow to Firm to Interest Expense	-356.19	-107.73	-93.90	33.33	91.06	166.59	177.59	164.45	100.06	133.84	220.45
Operating Cash Flow to Interest Expense	-57.59	-36.44	-39.72	6.28	4.57	20.42	-58.47	59.58	-59.17	65.06	58.70
Operating Cash Flow Less CapEx to Interest Expense	-80.37	-40.86	-45.43	3.70	3.88	19.85	-59.58	55.77	-67.62	50.45	56.22
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.45	0.47	0.49	0.51	0.52	0.55	0.55	0.61	0.62	0.64	0.64
Accounts Receivable Turnover	7.24	5.23	5.61	4.86	5.75	5.74	3.54	5.44	4.57	5.23	3.55
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	12.63	11.73	11.46	12.49	10.84	11.54	11.82	14.13	14.12	15.48	17.89
Accounts Payable Turnover	4.91	3.88	13.45	5.51	20.56	19.91	16.52	12.27	10.54	20.09	15.69
Days Sales Outstanding (DSO)	50.44	69.73	65.11	75.16	63.44	63.63	103.10	67.07	79.94	69.74	102.89
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	74.35	94.04	27.14	66.29	17.75	18.33	22.10	29.74	34.62	18.17	23.27
Cash Conversion Cycle (CCC)	-23.90	-24.31	37.97	8.87	45.69	45.30	81.00	37.33	45.32	51.57	79.62
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-44	-44	-46	-52	-56	-59	-59	-65	-66	-71	-77
Invested Capital Turnover	-1.12	-1.16	-1.15	-1.13	-1.07	-1.07	-1.09	-1.05	-1.04	-1.01	-1.03
Increase / (Decrease) in Invested Capital	3.54	2.38	0.57	-8.93	-11	-15	-13	-13	-9.98	-13	-18
Enterprise Value (EV)	170	169	156	209	228	242	351	223	342	371	615
Market Capitalization	241	235	217	270	289	303	409	283	400	431	677
Book Value per Share	$0.76	$0.61	$0.41	$0.25	$0.14	$0.06	($0.03)	($0.12)	($0.18)	($0.27)	($0.34)
Tangible Book Value per Share	$0.52	$0.38	$0.19	$0.05	($0.06)	($0.13)	($0.21)	($0.29)	($0.34)	($0.42)	($0.48)
Total Capital	27	22	15	9.55	5.28	2.21	-1.19	-4.82	-7.53	-11	-15
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-71	-66	-61	-61	-61	-61	-58	-60	-58	-60	-63
Capital Expenditures (CapEx)	0.62	0.34	0.43	0.20	0.05	0.03	0.05	0.18	0.36	0.72	0.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-28	-29	-29	-33	-39	-40	-34	-41	-39	-45	-45
Debt-free Net Working Capital (DFNWC)	27	17	12	12	7.18	8.56	9.80	0.87	-1.02	-5.74	9.19
Net Working Capital (NWC)	27	17	12	12	7.18	8.56	9.80	0.87	-1.02	-5.74	9.19
Net Nonoperating Expense (NNE)	3.09	2.24	4.07	3.01	3.14	2.14	3.23	2.73	3.36	2.89	2.58
Net Nonoperating Obligations (NNO)	-71	-66	-61	-61	-61	-61	-58	-60	-58	-60	-63
Total Depreciation and Amortization (D&A)	0.14	0.47	0.34	0.36	0.34	0.37	0.42	0.43	0.46	0.46	0.49
Debt-free, Cash-free Net Working Capital to Revenue	-54.75%	-55.19%	-54.31%	-61.42%	-72.38%	-73.27%	-58.97%	-67.61%	-61.63%	-67.84%	-64.34%
Debt-free Net Working Capital to Revenue	51.60%	33.34%	22.41%	22.41%	13.47%	15.64%	16.98%	1.41%	-1.61%	-8.71%	13.02%
Net Working Capital to Revenue	51.60%	33.34%	22.41%	22.41%	13.47%	15.64%	16.98%	1.41%	-1.61%	-8.71%	13.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.26)	($0.23)	($0.28)	($0.25)	($0.22)	($0.20)	($0.19)	($0.20)	($0.22)	($0.21)	($0.19)
Adjusted Weighted Average Basic Shares Outstanding	35.25M	36.01M	35.68M	37.71M	38.48M	39.30M	38.91M	40.85M	41.82M	42.74M	42.29M
Adjusted Diluted Earnings per Share	($0.26)	($0.23)	($0.28)	($0.25)	($0.22)	($0.20)	($0.19)	($0.20)	($0.22)	($0.21)	($0.19)
Adjusted Weighted Average Diluted Shares Outstanding	35.25M	36.01M	35.68M	37.71M	38.48M	39.30M	38.91M	40.85M	41.82M	42.74M	42.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.07M	36.85M	37.85M	38.48M	39.26M	40.18M	40.95M	41.98M	42.65M	43.68M	45.47M
Normalized Net Operating Profit after Tax (NOPAT)	-6.08	-5.92	-6.47	-6.39	-5.21	-5.54	-4.97	-5.40	-5.77	-6.10	-5.93
Normalized NOPAT Margin	-41.25%	-44.58%	-51.78%	-49.38%	-35.74%	-37.68%	-32.10%	-32.64%	-34.99%	-35.04%	-29.43%
Pre Tax Income Margin	-53.45%	-57.50%	-67.23%	-63.91%	-45.58%	-48.93%	-40.82%	-42.57%	-45.47%	-46.69%	-52.65%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-290.67	-98.12	-111.09	-107.87	-96.71	-129.89	-139.51	-145.63	-177.67	-164.86	-143.24
NOPAT to Interest Expense	-225.11	-76.85	-86.32	-84.13	-76.60	-100.79	-110.48	-112.41	-137.47	-124.49	-109.76
EBIT Less CapEx to Interest Expense	-313.44	-102.53	-116.80	-110.45	-97.40	-130.45	-140.62	-149.44	-186.12	-179.47	-145.72
NOPAT Less CapEx to Interest Expense	-247.89	-81.26	-92.03	-86.71	-77.29	-101.35	-111.59	-116.22	-145.92	-139.10	-112.24
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Below are the top takeaways from Arteris, Inc. (AIP) quarterly results over the last few years, focusing on what may matter most to retail investors. The company shows ongoing top‑line growth and very high gross margins, but remains unprofitable with negative equity and tight near‑term liquidity. A notable one‑off cash inflow from investments in 2025 temporarily boosted liquidity.

Revenue growth: Q4 2025 revenue was $20.137 million, up from $15.489 million in Q4 2024 and $12.504 million in Q4 2023, signaling a clear top‑line increase year over year.
Gross margins consistently high: Q4 2025 gross profit of $18.276 million on $20.137 million revenue implies a gross margin around 90% (similar margins appear in other recent quarters).
Large, one‑off investing cash inflows in 2025: Q4 2025 included a significant sale/maturity of investments (~$17.4 million) contributing to a sizable investing cash inflow and improving near‑term liquidity.
Net cash from investing activities positive in Q4 2025: Net cash from continuing investing activities was about $13.1 million, indicating ability to monetize investments for liquidity.
Cash on hand remains meaningful for a small cap: Cash & equivalents were in the mid‑teens to low‑20s millions range across 2024–2025 (e.g., roughly $17–22 million), providing near‑term liquidity runway.
Near‑term liquidity is tight but manageable: In several 2024–2025 periods, the current ratio hovered around 1.0 or slightly below (e.g., Q3 2025 current assets ~$61.0m vs. current liabilities ~$66.8m), indicating a tight liquidity position but not an immediate insolvency signal.
High operating costs relative to gross profit: SG&A plus marketing and RD expenses significantly exceed gross profit in multiple quarters, suggesting the cost structure needs substantial optimization to reach sustainable profitability.
Persistent net losses: Across 2025 quarters, net income was negative (e.g., Q4 2025 net income −$8.504 million; Q3 2025 −$8.991 million; Q2 2025 −$9.133 million; Q1 2025 −$8.121 million), reflecting ongoing profitability challenges.
Negative shareholders’ equity: By mid‑2025, total equity was negative (e.g., Q3 2025 equity around −$11.45 million), indicating the company has a deficit in net worth despite assets remaining above liabilities.
Operating expenses exceed gross profit: In recent quarters, total operating expenses (~$24–$26 million) exceeded total gross profit (~$14–$18 million), driving operating losses (e.g., Q4 2025 operating income −$6.467 million).

05/06/26 08:06 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Arteris' Financials

When does Arteris' financial year end?

According to the most recent income statement we have on file, Arteris' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Arteris' net income changed over the last 5 years?

Arteris' net income appears to be on an upward trend, with a most recent value of -$34.75 million in 2025, rising from -$3.26 million in 2020. The previous period was -$33.64 million in 2024. Find out what analysts predict for Arteris in the coming months.

What is Arteris' operating income?

Arteris' total operating income in 2025 was -$33.14 million, based on the following breakdown:

Total Gross Profit: $63.68 million
Total Operating Expenses: $96.82 million

How has Arteris' revenue changed over the last 5 years?

Over the last 5 years, Arteris' total revenue changed from $31.81 million in 2020 to $70.58 million in 2025, a change of 121.9%.

How much debt does Arteris have?

Arteris' total liabilities were at $129.66 million at the end of 2025, a 20.8% increase from 2024, and a 164.4% increase since 2020.

How much cash does Arteris have?

In the past 5 years, Arteris' cash and equivalents has ranged from $11.74 million in 2020 to $85.83 million in 2021, and is currently $33.90 million as of their latest financial filing in 2025.

How has Arteris' book value per share changed over the last 5 years?

Over the last 5 years, Arteris' book value per share changed from -0.68 in 2020 to -0.34 in 2025, a change of -51.0%.

Related Companies

Financial statements for NASDAQ:AIP last updated on 4/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arteris (AIP) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Arteris' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arteris (AIP) Financials

Annual Income Statements for Arteris

Quarterly Income Statements for Arteris

Annual Cash Flow Statements for Arteris

Quarterly Cash Flow Statements for Arteris

Annual Balance Sheets for Arteris

Quarterly Balance Sheets for Arteris

Annual Metrics And Ratios for Arteris

Quarterly Metrics And Ratios for Arteris

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Arteris' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools